Marvell Technology, Inc. Operating Cash Flow increased by 9.4% to $332.90M in Q1 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $324.50M to $332.90M. Over 2 years (FY 2023 to FY 2025), Operating Cash Flow shows an upward trend with a 14.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$13.70M | $540.00M | $411.00M | $194.80M | $126.10M | $503.00M | $464.90M | $208.40M | $422.50M | $536.30M | $203.30M | $324.50M | $470.00M | $582.30M | $304.40M | $332.90M |
| QoQ Change | — | >999% | -23.9% | -52.6% | -35.3% | +298.9% | -7.6% | -55.2% | +102.7% | +26.9% | -62.1% | +59.6% | +44.8% | +23.9% | -47.7% | +9.4% |
| YoY Change | — | — | — | >999% | -76.6% | +22.4% | — | +7.0% | +235.1% | +6.6% | -56.3% | +55.7% | +11.2% | +8.6% | +49.7% | +2.6% |